Wednesday, 28 August 2013

Glycosylated Fibronectin as a First-Trimester Biomarker for Prediction of Gestational Diabetes

First-trimester serum concentrations of glycosylated fibronectin, adiponectin, high-sensitivity C-reactive protein, and placental lactogen were significantly associated with Gestational Diabetes (Obstetrics & Gynecology)


Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease

Close follow-up of children with genetic risk enables early detection of T1D. Risk factors for rapid development of diabetes in this young population were first-degree relatives status and autoantibodies to glutamic acid decarboxylase (GADA), insulinoma-associated protein 2 (IA-2) and insulin (IAA) (Pediatric Diabetes)


Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine

Patients with T2DM initiating insulin glargine treatment showed low rates of hypoglycemia, especially when using a disposable pen device. Hypoglycemia-related costs were low, contributing a very small proportion to overall diabetes-related healthcare costs (Journal of Medical Economics)



No comments:

Post a Comment